NECTIN2 and Alzheimer disease: Among PVRL2 rs6859 AG/AA carriers, each 1 mmol/L higher level of LDL-C was significantly associated with 48% decreased risk of AD in model 2 (HR (95%CI) = 0.52 (0.33–0.84), p = .007, model 2).